Nemaura Medical Inc
Nemaura Medical Inc., a medical technology company, manufactures continuous glucose monitoring system in the United States. It offers sugarBEAT, a non-invasive continuous glucose monitoring device for use by persons with Type I and Type II diabetes, as well as screen pre-diabetic patients. The company also offers proBEAT, a wellness guidance notes, that provide prompts and educate users on factor… Read more
Nemaura Medical Inc (NMRD) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of December 2023: 0.083x
Based on the latest financial reports, Nemaura Medical Inc (NMRD) has a cash flow conversion efficiency ratio of 0.083x as of December 2023.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-1.48 Million) by net assets ($-17.83 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Nemaura Medical Inc - Cash Flow Conversion Efficiency Trend (2013–2023)
This chart illustrates how Nemaura Medical Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Nemaura Medical Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Nemaura Medical Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Bank of Tianjin Co Ltd
STU:B95
|
N/A |
|
EFG Hermes Pakistan Ltd
KAR:EFGH
|
N/A |
|
Son Ha Development of Renewable Energy JSC
VN:SHE
|
N/A |
|
SF REIT UTS
F:8ET
|
N/A |
|
Egyptians Real Estate Fund Certificates
EGX:EGREF
|
N/A |
|
Alphanam M&E
VN:AME
|
N/A |
|
HHGregg Inc. (IN)
PINK:HGGG
|
N/A |
|
creditshelf Aktiengesellschaft
F:CSQ
|
-2.968x |
Annual Cash Flow Conversion Efficiency for Nemaura Medical Inc (2013–2023)
The table below shows the annual cash flow conversion efficiency of Nemaura Medical Inc from 2013 to 2023.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2023-03-31 | $-11.81 Million | $-8.45 Million | 0.715x | +105.13% |
| 2022-03-31 | $466.08K | $-6.50 Million | -13.955x | -1844.54% |
| 2021-03-31 | $8.36 Million | $-6.00 Million | -0.718x | -127.31% |
| 2020-03-31 | $-1.31 Million | $-3.45 Million | 2.627x | +264.31% |
| 2019-03-31 | $2.23 Million | $-3.56 Million | -1.599x | -207.62% |
| 2018-03-31 | $4.11 Million | $-2.14 Million | -0.520x | -133.87% |
| 2017-03-31 | $5.37 Million | $-1.19 Million | -0.222x | -41.13% |
| 2016-03-31 | $7.68 Million | $-1.21 Million | -0.157x | -110.08% |
| 2015-03-31 | $-917.41K | $-1.43 Million | 1.562x | -61.19% |
| 2014-03-31 | $373.90K | $1.50 Million | 4.025x | +812.46% |
| 2013-03-31 | $-1.74 Million | $-768.31K | 0.441x | -- |